Latest stories on CGEN
Compugen to Participate in BTIG Biotechnology Conference 2026
PR Newswire56 · neutralgeneral
Compugen to Participate in BTIG Biotechnology Conference 2026 | CGEN Stock News
StockTitan56 · neutralgeneral
Compugen to Release Second Quarter 2026 Results on Monday, August 3, 2026
PR Newswire50 · neutralgeneral
Compugen Presents a Trial-in-Progress Poster on the MAIA-ovarian Adaptive Platform Trial at ESMO Gynaecological Cancers Congress
PR Newswire56 · neutralproduct/pr
Compugen Ltd. (CGEN) Discusses End-to-End AI-Driven Target Discovery in Immuno-Oncology Transcript
Seeking Alpha56 · neutralproduct/pr
Compugen to Present Phase 1 MAIA-Ovarian Trial-in-Progress Poster at ESMO Gynaecological Cancers Congress 2026 | CGEN Stock News
StockTitan63 · neutralproduct/pr
Compugen to Participate in Jones Trading Fireside Chat Series with Leaders in AI/ML-based Drug Development
PR Newswire56 · neutralproduct/pr
Solid Cash Position and Advancing Clinical Trials Define Compugen’s Q1 2026 Results
MarketChameleon67 · bullishearnings
Compugen: 'Buy' As Early Gastric Cancer Data Reinforces Rilvegostomig Program
Seeking Alpha63 · neutralanalyst
Compugen Ltd. (CGEN) Q1 2026 Earnings Call Transcript
Seeking Alpha50 · neutralearnings
Compugen Q1 Earnings Call Highlights
Yahoo Finance56 · neutralearnings
Compugen surges after revenue tops forecasts despite quarterly loss miss (CGEN)
Yahoo Top63 · neutralearnings
Compugen GAAP EPS of -$0.08 misses by $0.01, revenue of $2.18M beats by $0.92M
Seeking Alpha42 · neutralearnings
Compugen Reports First Quarter 2026 Results
PR Newswire56 · neutralearnings
Compugen Q1 2026 Earnings Preview
Seeking Alpha34 · bearishearnings
Compugen to Participate in 2026 Stifel Virtual Targeted Oncology Forum
PR Newswire56 · neutralproduct/pr